Micropulse Transscleral Cyclophotocoagulation: A Hypothesis for the Ideal Parameters

Area of Science:

• Ophthalmology
• Medical Technology
• Laser Surgery

Background:

• MicroPulse transscleral cyclophotocoagulation (mTSCPC) utilizes intermittent laser energy to minimize thermal damage.
• Existing literature indicates a favorable safety profile for mTSCPC compared to continuous-wave methods.
• Lack of standardized parameters hinders optimal treatment outcomes for mTSCPC.

Purpose of the Study:

• To review existing literature and identify ideal laser parameters for single-session mTSCPC.
• To establish a standardized energy range using Joules (J) for comparing treatment efficacy.
• To propose evidence-based dosimetry for mTSCPC based on desired intraocular pressure (IOP) reduction and risk.

Main Methods:

• Systematic review of clinical publications on mTSCPC.
• Standardization of laser energy levels across studies using Joules (J).
• Analysis of experimental data to refine optimal energy parameters.

Main Results:

• Literature review suggested a treatment range of 112-150 J for moderate IOP reduction (~30%) with minimal complications.
• Experimental data indicated a peak therapeutic effect at 150 J, potentially via a pilocarpine-like mechanism.
• Clinical safety data supports the use of parameters closer to 150 J.

Conclusions:

• Optimal single-session mTSCPC parameters may be near 150 J, balancing efficacy and safety.
• The concept of dosimetry for mTSCPC can be developed based on IOP goals and risk assessment.
• Further prospective studies are required to validate these findings and establish definitive treatment guidelines.